Status:
UNKNOWN
Use of a Smartphone Application to Increase Adherence to Medical Treatment in Patients With an Acute Coronary Syndrome.
Lead Sponsor:
Instituto Cardiovascular de Buenos Aires
Conditions:
Adherence, Medication
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
ADHERENCE is a randomized unicentric study that will be carried out from a monovalent center of cardiology of the Autonomous City of Buenos Aires. Patients will be randomized hospitalization for acute...
Detailed Description
The World Health Organization (WHO) states that poor adherence to long-term medical treatments severely compromises their effectiveness, with an expected adherence of 50% in developed countries and le...
Eligibility Criteria
Inclusion
- Patients over 18 years of age.
- Acquire hospitalization for acute coronary syndromes (ACS) with and without ST segment elevation.
- Have access to a smartphone in order to access the digital application provided.
- Have the possibility to follow up after 90 days.
- Sign the informed consent administered in writing prior to inclusion in the clinical trial.
Exclusion
- Patients with coronary lesions with a revascularization planned (revascularization in stages).
- Severe limitation of mobility (amputation, degenerative myopathies, musculoskeletal disorders).
- Total or intermediate dependency for carrying out tasks of daily life according to the validated Katz questionnaire of Activities of Daily Life (ADL). -
Key Trial Info
Start Date :
June 12 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 27 2019
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT03766789
Start Date
June 12 2018
End Date
January 27 2019
Last Update
December 19 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Juan Pablo Costabel
Buenos Aires, Argentina, 1428